BioMarin Pharmaceutical Inc. is a leading biotechnology company specializing in the development and commercialization of innovative therapies for rare genetic diseases. Established in 1997 and headqua... BioMarin Pharmaceutical Inc. is a leading biotechnology company specializing in the development and commercialization of innovative therapies for rare genetic diseases. Established in 1997 and headquartered in San Rafael, California, BioMarin is recognized for its deep expertise in genetics and molecular biology, with a primary focus on addressing unmet medical needs through targeted treatments. The company has introduced groundbreaking therapies for conditions such as achondroplasia, severe hemophilia A, phenylketonuria (PKU), and various lysosomal storage disorders, including mucopolysaccharidosis types I and VI. BioMarin operates globally, serving patients in over 70 countries and maintaining a significant presence in North America, Europe, Latin America, the Middle East, and Asia-Pacific. Its portfolio consists of eight approved medicines and a robust pipeline of clinical and preclinical candidates, aiming to advance the future of human health through transformative science. With dedicated manufacturing and research facilities, BioMarin's approach is anchored in targeting the root causes of genetic disorders, supporting its reputation as a pioneer in the biotechnology sector.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for BioMarin Pharmaceutical

We have not yet reviewed BioMarin Pharmaceutical's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review BioMarin Pharmaceutical's data?

Create a free Tracenable account to signal interest in having our team review data for BioMarin Pharmaceutical.

Legal Center Contact Us